Status:
RECRUITING
Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Delivery Complication
Cesarean Delivery Affecting Fetus
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Detailed Description
Cesarean delivery (CD) is one of the most common surgeries performed worldwide. In the last few decades, its rate has steadily increased worldwide, leading to an increase in maternal morbidity and mor...
Eligibility Criteria
Inclusion
- Singleton pregnancy
- Maternal age ≥ 18 years' old
- Oxytocin administration initiated or renewed during second stage of labor
Exclusion
- Maternal age \< 18 years' old
- Multiple gestation pregnancy
- Known fetal malformations
- Uterine scar
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06181396
Start Date
October 1 2023
End Date
October 1 2026
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam medical health campus
Haifa, Israel, 31999